A Proteins of ANL Family FACLs and FAALs, Next Anti TB Drug Targets.

Authors

DOI:

https://doi.org/10.14429/dlsj.9.19905

Keywords:

FACL, FAAL, Lipid metabolism, CoA binding pocket, Inhibitors, Tuberculosis

Abstract

The adenylating enzymes (AEs) of the ANL family contribute to the lipid synthesis process in Mycobacterium tuberculosis (MTB). FAALs (Fatty Acyl-AMP Ligase) and FACLs (Fatty Acyl-CoA Ligase) are members of the ANL enzyme family and are closely associated with the metabolism of mycobacterial lipids responsible for successful infections. Therefore, given their role in both biosynthesis and breakdown processes within fatty acid metabolism, these two groups of proteins might be potential drug targets. The growing abundance of structural, biochemical, and genetic information on mycobacterial FAAL and FACL enzymes could provide a solid foundation for the creation of next-generation anti-tuberculosis drugs, via rational drug designing.  

Downloads

Published

2024-09-26

How to Cite

Chakraborty, A., Kalam, M., Sarkar, S., Roy, D., Bhattacharjee, M., Paul, D., Banerjee, A., & Gupta, D. P. (2024). A Proteins of ANL Family FACLs and FAALs, Next Anti TB Drug Targets. Defence Life Science Journal, 9(4), 307–315. https://doi.org/10.14429/dlsj.9.19905

Issue

Section

Research Article